Related Experiment Video
Updated: Oct 9, 2025

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
Malassezia restricta Pneumonia in Solid Organ Transplant Recipients: First Report of Two Cases
Alessandra Mularoni1, Elena Graziano1,2, Alice Annalisa Medaglia3
1Department of Infectious Diseases, IRCCS-ISMETT (Mediterranean Institute for Transplantation and Advanced Specialized Therapies), 90127 Palermo, Italy.
Abstract:
Emerging fungal infections are a major challenge in solid organ transplantation (SOT) and are associated with high morbidity and mortality. We report two cases of Malassezia restricta pneumonia in SOT recipients. Infections were diagnosed with molecular analysis and histology. Patients were treated with antifungal therapy and have fully recovered.
Insights
Emerging fungal infections pose significant risks for solid organ transplant recipients. This report details two successful treatments of Malassezia restricta pneumonia in these patients, highlighting effective antifungal therapy.
Area of Science:
- Mycology
- Infectious Diseases
- Transplantation Medicine
Background:
- Emerging fungal infections present a substantial clinical challenge in solid organ transplantation (SOT).
- These infections are frequently linked to increased patient morbidity and mortality rates.
- Early diagnosis and prompt treatment are crucial for improving outcomes in SOT recipients.
Observation:
- Two cases of pneumonia caused by Malassezia restricta were identified in solid organ transplant recipients.
- The diagnosis was confirmed through a combination of molecular analysis and histological examination.
- Both patients presented with symptoms indicative of a severe respiratory infection.
Findings:
- Molecular and histological analyses confirmed Malassezia restricta as the causative agent.
- Both SOT recipients received targeted antifungal therapy.
- The patients demonstrated a complete recovery following treatment.
Implications:
- This case report underscores the importance of considering Malassezia species in the differential diagnosis of pneumonia in SOT patients.
- Effective antifungal treatment can lead to successful patient recovery.
- Further research into the epidemiology and management of Malassezia infections in immunocompromised populations is warranted.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

